tiprankstipranks
Hansa Biopharma AB (SE:HNSA)
:HNSA
Sweden Market
HNSA
Hansa Biopharma AB
RESEARCH TOOLSreports

Hansa Biopharma AB (HNSA) Cash flow

16 Followers

Hansa Biopharma AB Cash Flow

SE:HNSA's free cash flow for Q4 2025 was kr-177.54M. For the 2025 fiscal year, SE:HNSA's free cash flow was decreased by kr125.83M and operating cash flow was kr-177.54M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
kr -549.17Mkr -674.88Mkr -755.65Mkr -502.73Mkr -481.17M
Investing Cash Flow
kr 0.00kr -116.00Kkr -284.00Kkr 229.31Mkr -2.40M
Financing Cash Flow
kr 847.96Mkr 346.81Mkr -7.54Mkr 1.12Bkr -4.86M
End Cash Position
kr 701.08Mkr 405.28Mkr 732.06Mkr 1.50Bkr 651.34M
Free Cash Flow
kr -549.17Mkr -675.00Mkr -755.94Mkr -506.06Mkr -483.57M
Currency in SEK

Hansa Biopharma AB Cash Flow